Lynch S, Baker S, Nashatizadeh M, Thuringer A, Huebner J, Bruce J. A description of processing speed, learning and memory in people with multiple sclerosis aged 55. Mult Scler Relat Disord. 2025 Jun;98:106415. PubMed PMID: 40262474
Huebner J, Robichaud J, Cozart JS, Burkhardt C, Lynch SG, Bruce JM. Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Cognitive Performance in Adults With Multiple Sclerosis. Int J MS Care. 2024 Mar-Apr;26(2):81-88. PubMed PMID: 38482514
Pradeep Kumar D, Zanotto T, Cozart JS, Bruce AS, Befort C, Siengsukon C, Shook R, Lynch S, Mahmoud R, Simon S, Hibbing PR, Drees B, Huebner J, Bradish T, Robichaud J, Sosnoff JJ, Bruce JM. Association between frailty and sleep quality in people living with multiple sclerosis and obesity: An observational cross-sectional study. Mult Scler Relat Disord. 2024 Jan;81:105154. PubMed PMID: 38043367
Gold SM, Friede T, Meyer B, Moss-Morris R, Hudson J, Asseyer S, Bellmann-Strobl J, Leisdon A, Ißels L, Ritter K, Schymainski D, Pomeroy H, Lynch SG, Cozart JS, Thelen J, Román CAF, Cadden M, Guty E, Lau S, Pöttgen J, Ramien C, Seddiq-Zai S, Kloidt AM, Wieditz J, Penner IK, Paul F, Sicotte NL, Bruce JM, Arnett PA, Heesen C. Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial. Lancet Digit Health. 2023 Oct;5(10):e668-e678. PubMed PMID: 37775187
Bruce JM, Cozart JS, Shook RP, Befort C, Siengsukon CF, Simon S, Lynch SG, Mahmoud R, Drees B, Posson P, Hibbing PR, Huebner J, Bradish T, Robichaud J, Bruce AS. Modifying diet and exercise in multiple sclerosis (MoDEMS): A randomized controlled trial for behavioral weight loss in adults with multiple sclerosis and obesity. Mult Scler. 2023 Dec;29(14):1860-1871. PubMed PMID: 38018409
Echemendia RJ, Thelen J, Meeuwisse W, Comper P, Hutchison MG, Rizos J, Bruce JM. The Utility of the King-Devick Test in Evaluating Professional Ice Hockey Players With Suspected Concussion. Clin J Sport Med. 2022 May 1;32(3):265-271. PubMed PMID: 32941373
Bruce JM, Meeuwisse W, Thelen J, Hutchison MG, Comper P, Echemendia RJ. A Cross-Sectional Decision-Making Approach to Inform Neuropsychological Battery Development in Professional Hockey. Arch Clin Neuropsychol. 2022 Feb 22;37(3):621-632. PubMed PMID: 34929026
Thelen J, Zvonarev V, Lam S, Burkhardt C, Lynch S, Bruce J. Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions. Mo Med. 2021 May-Jun;118(3):239-245. PubMed PMID: 34149084
Echemendia RJ, Thelen J, Meeuwisse W, Hutchison MG, Rizos J, Comper P, Bruce JM. Erratum to: Neuropsychological Assessment of Professional Ice Hockey Players: A Cross-Cultural Examination of Baseline Data Across Language Groups. Arch Clin Neuropsychol. 2021 May 21;36(4):639. PubMed PMID: 33693523
Lynch S, Baker S, Nashatizadeh M, Thuringer A, Thelen J, Bruce J. Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?. Mult Scler Relat Disord. 2021 Apr;49:102724. PubMed PMID: 33609959
Jarmolowicz DP, Reed DD, Schneider TD, Smith J, Thelen J, Lynch S, Bruce AS, Bruce JM. Behavioral economic demand for medications and its relation to clinical measures in multiple sclerosis. Exp Clin Psychopharmacol. 2020 Jun;28(3):258-264. PubMed PMID: 31556674
Echemendia RJ, Thelen J, Meeuwisse W, Comper P, Hutchison MG, Bruce JM. Testing the hybrid battery approach to evaluating sports-related concussion in the National Hockey League: A factor analytic study. Clin Neuropsychol. 2020 Jul;34(5):899-918. PubMed PMID: 31777320
Rasu RS, Thelen J, Agbor Bawa W, Goggin K, Bradley-Ewing A, Catley D. Motivational Interviewing to Encourage Quit Attempts Among Smokers Not Ready to Quit: A Trial-Based Economic Analysis. Nicotine Tob Res. 2020 Aug 24;22(9):1515-1523. PubMed PMID: 31820002
Echemendia RJ, Thelen J, Meeuwisse W, Hutchison MG, Rizos J, Comper P, Bruce JM. Neuropsychological Assessment of Professional Ice Hockey Players: A Cross-Cultural Examination of Baseline Data Across Language Groups. Arch Clin Neuropsychol. 2020 Apr 20;35(3):240-256. PubMed PMID: 31897473
Glusman M, Bruce A, Thelen J, Smith J, Lynch S, Catley D, Bennett KK, Bruce J. Discontinuing Treatment Against Medical Advice: The Role of Perceived Autonomy Support From Providers in Relapsing-Remitting Multiple Sclerosis. Ann Behav Med. 2019 Mar 1;53(3):283-289. PubMed PMID: 29771271
Schoor R, Bruce A, Bruce J, Goggin K, Schanfarber B, Bradley-Ewing A, Thelen J, Glusman M, Lynch SG, Strober L, Catley D. Reasons for nonadherence and response to treatment in an adherence intervention trial for relapsing-remitting multiple sclerosis patients. J Clin Psychol. 2019 Mar;75(3):380-391. PubMed PMID: 30485422
Bruce JM, Bruce AS, Lynch S, Thelen J, Lim SL, Smith J, Catley D, Reed DD, Jarmolowicz DP. Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence. Psychopharmacology (Berl). 2018 Nov;235(11):3303-3313. PubMed PMID: 30244284
Bruce JM, Jarmolowicz DP, Lynch S, Thelen J, Lim SL, Smith J, Catley D, Bruce AS. How patients with multiple sclerosis weigh treatment risks and benefits. Health Psychol. 2018 Jul;37(7):680-690. PubMed PMID: 29863373
Smith J, Bruce AS, Glusman M, Thelen J, Lynch S, Bruce JM. Determining reliable change on the modified fatigue impact scale (5-item version). Mult Scler Relat Disord. 2018 Feb;20:22-24. PubMed PMID: 29275058
Thelen J, Bruce A, Catley D, Lynch S, Goggin K, Bradley-Ewing A, Glusman M, Norouzinia A, Strober L, Bruce J. Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention. J Behav Med. 2018 Apr;41(2):253-260. PubMed PMID: 29124557
Clausen AN, Francisco AJ, Thelen J, Bruce J, Martin LE, McDowd J, Simmons WK, Aupperle RL. PTSD and cognitive symptoms relate to inhibition-related prefrontal activation and functional connectivity. Depress Anxiety. 2017 May;34(5):427-436. PubMed PMID: 28370684
Jarmolowicz DP, Bruce AS, Glusman M, Lim SL, Lynch S, Thelen J, Catley D, Zieber N, Reed DD, Bruce JM. On how patients with multiple sclerosis weigh side effect severity and treatment efficacy when making treatment decisions. Exp Clin Psychopharmacol. 2017 Dec;25(6):479-484. PubMed PMID: 29251977
Bruce J, Bruce A, Lynch S, Strober L, O'Bryan S, Sobotka D, Thelen J, Ness A, Glusman M, Goggin K, Bradley-Ewing A, Catley D. A pilot study to improve adherence among MS patients who discontinue treatment against medical advice. J Behav Med. 2016 Apr;39(2):276-87. PubMed PMID: 26563147
Roberg BL, Somogie M, Thelen JM, Bruce JM. Articulation time does not affect speeded cognitive performance in multiple sclerosis. Cogn Behav Neurol. 2015 Mar;28(1):33-8. PubMed PMID: 25812129
Thelen JM, Lynch SG, Bruce AS, Hancock LM, Bruce JM. Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance. J Psychosom Res. 2014 May;76(5):400-4. PubMed PMID: 24745782